“…Most early investigations into RiPP natural products have been bioactivity-guided efforts leading to notable discoveries such as nisin, microcin B17, and darobactin. − Advances in bioinformatic technologies, such as antiSMASH, BAGEL, RODEO, RiPPer, the tools of the Enzyme Function Initiative, and many others, have enabled rapid identification of RiPP BGCs within the ever-growing genome databases. ,− Consequently, renewed efforts have focused on the discovery of novel RiPPs by genome mining (e.g., refs and − ). In addition, many studies have reported engineering of RiPP pathways to make new-to-nature structures and hybrid RiPPs. ,− A current bottleneck in such research is the identification of proteases that recognize the cognate RiPPs and remove the LP to yield the final, mature compound.…”